Archive: 10/6/2010

Johnson & Johnson, Crucell biotech announce takeover

Pharmaceutical and health care giant Johnson & Johnson has reached a deal with Dutch biotechnology vaccine group Crucell to buy 82.5 percent of Crucell for about 1.75 billion euros, the two firms said on Wednesday.

dateOct 06, 2010 in Other
shares0 comments 0

Euro terror alert spotlights voiceprint technology

(AP) -- Did their voices betray them? The discovery of an alleged terror plot against Europe owes at least some of its success to "voiceprint" technology that allows law enforcement to electronically match ...

dateOct 06, 2010 in Software
shares0 comments 0